Berberine Protects against TNF-α-Induced Injury of Human Umbilical Vein Endothelial Cells via the AMPK/NF-κB/YY1 Signaling Pathway

• Published in: Evidence-based complementary and alternative medicine Vol. 2021; pp. 6518355 - 13
• Main Authors: Chen, Li, Fan, Xiao-Di, Qu, Hua, Bai, Rui-Na, Shi, Da-Zhuo
• Format: Journal Article
• Language: English
• Published: United States Hindawi 2021; Hindawi Limited
• Subjects: AMP; Antibodies; Antidiabetics; Antioxidants; Arteriosclerosis; Atherosclerosis; Berberine; Cell growth; Cytokines; Diabetes mellitus; Endothelial cells; Endothelium; Enzyme-linked immunosorbent assay; Enzymes; Flow cytometry; Gene expression; IL-1β; Immunofluorescence; Inflammation; Interleukin 6; Interleukin 8; Kinases; NF-κB protein; Permeability; Polymerase chain reaction; Protein kinase; Proteins; Signal transduction; Tumor necrosis factor-TNF; Tumor necrosis factor-α; Umbilical vein; YY1 protein; United States > US; China
• ISSN: 1741-427X; 1741-4288
• DOI: 10.1155/2021/6518355

Endothelial injury, characterized by an inflammatory response and increased permeability, is an initial stage of atherosclerosis (AS). Adenosine 5′-monophosphate (AMP), activated protein kinase (AMPK), and Nuclear Factor kappa B (NF-κB)/Yin Yang 1(YY1) signaling pathways play important roles in the process of endothelial injury. Berberine (BBR), a bioactive alkaloid isolated from several herbal substances, possesses multiple pharmacological effects, including anti-inflammatory, antimicrobial, antidiabetic, anticancer, and antioxidant activities. Previous studies showed a protective effect of berberine against endothelial injury. However, the underlying mechanism remains unclear. We explored the potential effect of BBR on TNF- (tumor necrosis factor-) α-induced injury of human umbilical endothelial cells (HUVECs) and studied its possible molecular mechanism. In the present study, HUVECs were divided into three groups. HUVEC viability was measured with Cell Counting Kit-8 assay. Extracellular lactic dehydrogenase (LDH) concentration was measured with LDH leakage assay. Endothelial microparticle (EMP) numbers were evaluated by flow cytometry analysis assay. The expression of proinflammatory cytokines was evaluated by Enzyme-Linked Immunosorbent Assay (ELISA). The mRNA expression of NF-κB and YY1 was detected by Real-Time PCR (RT-PCR). The protein expression of NF-κB, YY1, and AMPK was detected by immunofluorescence microscopy assay or western blot analysis. The results showed that LDH concentration, EMPs numbers, and the expression of proinflammatory cytokines (IL-6, IL-8, and IL-1β) increased in TNF-α-induced injured HUVECs, but ameliorated by BBR pretreatment. BBR pretreatment upregulated the expression of phosphorylated AMPK and downregulated the expressions of NF-κB and YY1 in injured HUVECs induced by TNF-α, which were offset by the AMPK inhibitor Compound C (CC). The results indicated that BBR protected against TNF-α-induced endothelial injury via the AMPK/NF-κB/YY1 signaling pathway.